These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28600787)

  • 1. Unbalanced Growth, Senescence and Aging.
    Polymenis M; Kennedy BK
    Adv Exp Med Biol; 2017; 1002():189-208. PubMed ID: 28600787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging and cancer: the double-edged sword of replicative senescence.
    Campisi J
    J Am Geriatr Soc; 1997 Apr; 45(4):482-8. PubMed ID: 9100719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence.
    Bernadotte A; Mikhelson VM; Spivak IM
    Aging (Albany NY); 2016 Jan; 8(1):3-11. PubMed ID: 26805432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular senescence and age-related diseases].
    Nakanishi M
    Rinsho Ketsueki; 2019; 60(9):1027-1032. PubMed ID: 31597824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common signature of cellular senescence; does it exist?
    Sikora E; Bielak-Zmijewska A; Mosieniak G
    Ageing Res Rev; 2021 Nov; 71():101458. PubMed ID: 34500043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient sensing, growth and senescence.
    Carroll B; Korolchuk VI
    FEBS J; 2018 Jun; 285(11):1948-1958. PubMed ID: 29405586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The centrosome and mitotic spindle apparatus in cancer and senescence.
    Schmidt S; Essmann F; Cirstea IC; Kuck F; Thakur HC; Singh M; Kletke A; Jänicke RU; Wiek C; Hanenberg H; Ahmadian MR; Schulze-Osthoff K; Nürnberg B; Piekorz RP
    Cell Cycle; 2010 Nov; 9(22):4469-73. PubMed ID: 21088502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response.
    Jurk D; Wang C; Miwa S; Maddick M; Korolchuk V; Tsolou A; Gonos ES; Thrasivoulou C; Saffrey MJ; Cameron K; von Zglinicki T
    Aging Cell; 2012 Dec; 11(6):996-1004. PubMed ID: 22882466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence in RASopathies, a possible novel contributor to a complex pathophenoype.
    Engler M; Fidan M; Nandi S; Cirstea IC
    Mech Ageing Dev; 2021 Mar; 194():111411. PubMed ID: 33309600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imperfect asymmetry: The mechanism governing asymmetric partitioning of damaged cellular components during mitosis.
    Pattabiraman S; Kaganovich D
    Bioarchitecture; 2014; 4(6):203-9. PubMed ID: 25941938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mechanism of Programmed Aging: The Way to Create a Real Remedy for Senescence.
    Trubitsyn AG
    Curr Aging Sci; 2020; 13(1):31-41. PubMed ID: 31660847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting metabolism in cellular senescence, a role for intervention.
    Nacarelli T; Sell C
    Mol Cell Endocrinol; 2017 Nov; 455():83-92. PubMed ID: 27591812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular aging beyond cellular senescence: Markers of senescence prior to cell cycle arrest in vitro and in vivo.
    Ogrodnik M
    Aging Cell; 2021 Apr; 20(4):e13338. PubMed ID: 33711211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology of replicative senescence.
    Campisi J
    Eur J Cancer; 1997 Apr; 33(5):703-9. PubMed ID: 9282108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential.
    Demidenko ZN; Blagosklonny MV
    Aging (Albany NY); 2009 Dec; 1(12):1008-16. PubMed ID: 20157583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric cell division and replicative aging: a new perspective from the spindle poles.
    Manzano-López J; Monje-Casas F
    Curr Genet; 2020 Aug; 66(4):719-727. PubMed ID: 32266430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mechanism of mammalian target of rapamycin in age-related renal cell senescence and organ aging.
    Zhuo L; Cai G; Liu F; Fu B; Liu W; Hong Q; Ma Q; Peng Y; Wang J; Chen X
    Mech Ageing Dev; 2009 Oct; 130(10):700-8. PubMed ID: 19698731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell aging in vivo and in vitro.
    Rubin H
    Mech Ageing Dev; 1997 Oct; 98(1):1-35. PubMed ID: 9255755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms.
    Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D
    J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cellular senescence on metabolic pathways in non-immune and immune cells.
    Frasca D; Saada YB; Garcia D; Friguet B
    Mech Ageing Dev; 2021 Mar; 194():111428. PubMed ID: 33383073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.